Pin Lu

机构：Fox Chase Cancer Center, University of South China

发表论文 87 篇 · 总被引 1292 次 · h-index 16

代表论文

• Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication (2021 · Blood Cancer Journal · 被引 52)
• Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2 (2021 · Blood Advances · 被引 17)
• SHP1 loss augments DLBCL cellular response to ibrutinib: a candidate predictive biomarker (2022 · Oncogene · 被引 6)
• Leukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL) (2023 · Molecular Case Studies · 被引 5)
• Ibrutinib and Venetoclax Target Distinct Subpopulation of CLL Cells: Rationale for Drug Combination and Implication of Minimal Residual Disease Eradication (2019 · Blood · 被引 3)
• Shelter in place: live CLL cells inside the bone marrow fibroblasts and its implication in residual disease persistence (2025 · Blood Neoplasia · 被引 1)